Company profile
Medifast, Inc.
NYSE: MED · Consumer Cyclical · Personal Products & Services
#320 of 620 Consumer Cyclical companies by revenuebottom-decile growth
EA Score
52DFH 47DQ 77GM 16SS 56
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, Altman-Z · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$346.1M
Rev growth YoY (TTM)
-36.3%
Net income (FY)
-$18.7M
Employees
380
as of 2026-09-15
Market cap
$133.4M
as of 2026-09-15
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$385.8M$385.8M2025
Net income-$18.7M-$18.7M2025
Operating income-$14.2M-$14.2M2025
Total assets$248.0M$248.0M2025
Liabilities$49.1M$49.1M2025
Equity$198.9M$198.9M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY21
FY23
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2017
By product
Optavia85%
Medifast Direct11%
Franchise Weight Control Centers4%
Medifast Wholesale Physicans0%
By geography
Not disclosed.
The read
What is Medifast, Inc.’s revenue?
Medifast, Inc. booked $385.8M in FY2025 revenue, contracting 36% year over year — among the slowest-growing Consumer Cyclical companies we track, at a -4.8% net margin.
Peers · Consumer Cyclical
ChargePoint Holdings, Inc.27DBiglari Holdings Inc.50DBARK, Inc.34DEVgo, Inc.41DProliance International, Inc.——Christopher & Banks Corporation——Neighbors
Baltimore (Independent City) →Key facts
CEONicholas Johnson
SectorConsumer Cyclical
IndustryPersonal Products & Services
HeadquartersBaltimore, MD
ExchangeNYSE: MED
Employees380
IPO date1993-12-30
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.